Brain Disorders & Therapy

International Conference on Brain Disorders & Therapeutics

August 24-26, 2015 London, UK

Scientific Tracks Abstracts

• Working memory in 6 years old children and cognitive training

  Anna Orylska1, Krzysztof Rzenca2, Blazej Mrozinski1 and Grzegorz Sedek1

  PDF HTML

• Cytotoxic edema after traumatic brain injury a new hypothesis to its etiology

  Hans Von Holst

  PDF HTML

• The correlation between binaural perception and brain stem lesions

  Miriam Furst

  PDF HTML

• Perioperative stroke

  Alex Bekker

  PDF HTML

• Cerebral response to auditory attractiveness and auditory hallucinations in schizophrenia: An fMRI study for understanding social cognitive function

  Michihiko Koeda

  PDF HTML

• Epilepsy and its management in relation to Psychiatry

  Amir Mufaddel

  PDF HTML

• Blocking LINGO-1 for CNS remyelination and repair: From discovery to clinical trials

  Sha Mi

  PDF HTML

• Postoperative cognitive decline in the elderly

  Alex Bekker

  PDF HTML

• A different perspective to white matter disorders leads to a new clinical approach for diagnosing leukodystrophies

  Nasser Nadim

  PDF HTML

• Technology based behavioral vaccines to prevent depression in Adolescents

  Benjamin Van Voorhees

  PDF HTML

• Marchiafava-Bignami Disease (MBD) and diffusion tensor image (DTI) tractography

  Priscilla Chukwueke

  PDF HTML

• The potential role of venous haemodynamics in some brain pathologies

  Eleuterio F Toro

  PDF HTML

• The active function of venous brain system into hemodynamic brain circulation

  J Hemza

  PDF HTML

• Tumor suppressor WWOX limits neurodegeneration and Zfra mitigates the symptoms of Alzheimerâ??s disease

  Nan-Shan Chang, Jean-Yun Chang, Ming-Hui Lee and Sing-Ru Lin

  PDF HTML

• Immunoproteasome in neuroinflammation

  Michele Mishto

  PDF HTML

• Evaluation of neuroprotective effect of silk protein, sericin in Alzheimerâ??s disease induced rat brain

  K Yellamma and K Peera

  PDF HTML

• The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury

  Mark S Kindy

  PDF HTML

• Retro-inverso peptide inhibitors of β-amyloid oligomer formation as a novel treatment for the progression of Alzheimerâ??s disease

  David Allsop

  PDF HTML

• Mining the A. nidulans metabolome for tau aggregation inhibitors

  T Chris Gamblin1, S R Paranjape1, Y M Chiang2,4, C Wang2, B R Oakley1 and T C Gamblin1

  PDF HTML

• Variation in response to short-term anti-depressant treatment between patients with continuous and non-continuous cycling bipolar disorders

  Rocco de Filippis

  PDF HTML

• Novel peptides for anti-amyloid therapy and MRI diagnosis in Alzheimerâ??s disease

  Brian Austen

  PDF HTML

• Anti-inflammation and neuroprotective drugs benefit the treatment of bipolar II disorder patients

  Ru-Band Lu, Sheng-Yu Lee, Shiou-Lan Chen and Yun-Hsuan Chang

  PDF HTML

• Smartphone app for the brain, the vagus nerve and the therapy depression and anxiety

  Christopher J Lahr and Ryan Marshal

  PDF HTML

• A novel hypothesis to the origin of autism: An alteration in biological water dynamics disrupts proton-coupled electron transfer and the organizing function of CNS fractones

  Robert Michael Davidson

  PDF HTML

• Characterization of micro particles derived from cultured macrophages and cerebrospinal fluid of patients with schizophrenic and affective disorders

  E Marion Schneider1, Haouraa Mostafa, Fabian Zink, Karl Bechter, Maximillian Strunz and Robert Loewe

  PDF HTML

• Targeting Neurotoxic N-Terminal Pyroglutamated Abeta (Pgluaβ) with inhibitors of Glutaminyl Cyclase (Qc) and Pgluaβ-specific antibodies has reached clinical stage

  Hans-Ulrich Demuth

  PDF HTML

• Error augmentation as a possible technique for improving upper extremity motor performance after a stroke: A pilot study

  Eli Carmeli, Sharon Israely and Sara Rosenblum

  PDF HTML

• The influence of mitochondrin-2 and cerebrolysin on the survival of Drosophila melanogaster individuals with the functional knockout of Sod1 gene in glia

  Makarenko O M, Matiytsiv N, Vitushynska M and Chernyk Ya

  PDF HTML

• The role of amyloid beta peptide variability toward progress of Alzheimer disease

  Kerensa Broersen

  PDF HTML

• Characterization of a mouse model of subarachnoid haemorrhage: Involvement of the urotensin II peptide system on vasospasm and neuro sensitive motor deficits

  H Castel1, M Dubois, A Mutel, T Clavier, L Desrues, S Curey, G Gastaldi, A Mellot, F Morin, P Gandolfo, V Compere, F Proust and M El-Amki

  PDF HTML

• Targeting I²1-adrenergic receptor as a novel therapeutic approach for treatment of Alzheimers disease

  Mehrdad Shamloo, Pooneh Memar, Ardestani and Bitna Yi

  PDF HTML

• Central nervous system (CNS) calcifications as a differential diagnosis of psychiatric disorders

  Amir Mufaddel

  PDF HTML

• Neurological disorders in children / the sheikhâ??s syndrome

  Shahid Hussain Sheikh

  PDF HTML

• Gene expression changes triggered by amyloid beta toxicity

  Wail M Hassan

  PDF HTML

• Test battery approach to cognitive communication disorders in traumatic brain injury

  Reeta Jaya Philip, Daly Sebastian, B S Premalatha and Smita Malhotra

  PDF HTML

• Investigation of auditory temporal processing in Brocaâ??s aphasics with phonological paraphasia: New dimension towards temporal cue based language rehabilitation

  Daly Sebastian and Geetha Mukundan

  PDF HTML